SEC Comment Letter 0000000000-24-001554 to GENELUX Corp (GNLX)
GENELUX Corp
Date: Feb. 8, 2024 · CIK: 0001231457 · Accession: 0000000000-24-001554
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-276847
Letter
United States securities and exchange commission logo February 8, 2024 Thomas Zindrick Chief Executive Officer Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village, CA 91361 Re:Genelux Corporation Registration Statement on Form S-3 Filed February 2, 2024 File No. 333-276847 Dear Thomas Zindrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Christine Kim
Show Raw Text
United States securities and exchange commission logo
February 8, 2024
Thomas Zindrick
Chief Executive Officer
Genelux Corporation
2625 Townsgate Road, Suite 230
Westlake Village, CA 91361
Re:Genelux Corporation
Registration Statement on Form S-3
Filed February 2, 2024
File No. 333-276847
Dear Thomas Zindrick:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Christine Kim